Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ani Pharmaceuticals (ANIP) Total Non-Current Liabilities (2016 - 2026)

Ani Pharmaceuticals' Total Non-Current Liabilities history spans 14 years, with the latest figure at $890.0 million for Q4 2025.

  • On a quarterly basis, Total Non-Current Liabilities rose 5.33% to $890.0 million in Q4 2025 year-over-year; TTM through Dec 2025 was $890.0 million, a 5.33% increase, with the full-year FY2025 number at $890.0 million, up 5.33% from a year prior.
  • Total Non-Current Liabilities hit $890.0 million in Q4 2025 for Ani Pharmaceuticals, roughly flat from $891.1 million in the prior quarter.
  • Over the last five years, Total Non-Current Liabilities for ANIP hit a ceiling of $891.1 million in Q3 2025 and a floor of $251.8 million in Q1 2021.
  • Historically, Total Non-Current Liabilities has averaged $527.7 million across 5 years, with a median of $424.6 million in 2023.
  • Biggest five-year swings in Total Non-Current Liabilities: decreased 5.87% in 2021 and later surged 103.87% in 2025.
  • Tracing ANIP's Total Non-Current Liabilities over 5 years: stood at $405.1 million in 2021, then rose by 3.73% to $420.2 million in 2022, then increased by 5.2% to $442.0 million in 2023, then soared by 91.18% to $845.0 million in 2024, then grew by 5.33% to $890.0 million in 2025.
  • Business Quant data shows Total Non-Current Liabilities for ANIP at $890.0 million in Q4 2025, $891.1 million in Q3 2025, and $874.7 million in Q2 2025.